This inventor holds 1 USPTO granted patent. Top assignee: Acib Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christoph Oehlknecht: Innovator in Biochemistry
Introduction
Christoph Oehlknecht is a notable inventor based in Graz, Austria. He has made significant contributions to the field of biochemistry, particularly through his innovative work on caspase-2 variants. His research has implications for understanding apoptosis and cellular processes.
Latest Patents
Oehlknecht holds a patent for "Caspase-2 Variants," which showcases his expertise in the biochemical domain. This patent represents a crucial advancement in the study of cell death mechanisms and their potential applications in therapeutic interventions. He has 1 patent to his name.
Career Highlights
Christoph Oehlknecht is currently employed at Acib GmbH, a research institution dedicated to advancing biotechnological innovations. His role at Acib GmbH allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Oehlknecht has worked alongside esteemed colleagues such as Rainer Schneider and Gerald Striedner. These collaborations have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Christoph Oehlknecht is a prominent figure in biochemistry, with a focus on caspase-2 variants. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile